Latest Breaking News On - Eva kalias - Page 5 : comparemela.com

Santhera Pharmaceuticals Holding AG: Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update

Santhera Pharmaceuticals Holding AG: Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSwitzerland generalNew yorkBaden wübergDario eklundChiesi farmaceuticiAndrew smithShabir hashamEva kaliasChiesi groupEuropean medicines agencyCommittee for medicinal products human useAdvisory committee meetingEuropean commissionLife science alliance

Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update

Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew yorkSwitzerland generalAndrew smithShabir hashamEva kaliasDario eklundChiesi farmaceuticiRegulatory agencyAmerica to catalyst pharmaceuticalsCatalyst pharmaceuticals incSanthera pharmaceuticalsWorld muscle societyHead investor relations communicationsEuropean union

Santhera Completes Divestment of Raxone®/Idebenone Business to Chiesi Group

Santhera Completes Divestment of Raxone®/Idebenone Business to Chiesi Group
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSwitzerland generalGiacomo chiesiChiesi farmaceuticiDario eklundEva kaliasRegulatory agencyHead investor relations communicationsIdebenone business to chiesi groupB corpSanthera pharmaceuticalsChiesi groupAmerica to catalyst pharmaceuticalsSanthera pharmaceuticals holdingEuropean medicines agency

Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone

Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited kingdomUnited statesDario eklundEva kaliasHead investor relations communicationsAmerica to catalyst pharmaceuticalsSanthera pharmaceuticals holdingLife science allianceEuropean medicines agencyChiesi groupRegulatory agencyCatalyst pharmaceuticals incSanthera pharmaceuticalsNorth americaCatalyst pharmaceuticals

Santhera Pharmaceuticals Holding AG: Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone

Santhera Pharmaceuticals Holding AG: Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSwitzerland generalDario eklundEva kaliasSanthera pharmaceuticals holdingHead investor relations communicationsSanthera pharmaceuticalsEuropean medicines agencyCatalyst pharmaceuticals incLife science allianceNorth americaCatalyst pharmaceuticalsHighbridge capitalChief executive officerHart scott rodino antitrust improvements